ArticleEuropean journal of nuclear medicine and molecular imaging2014

Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT).

G Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.